Healthcare Services

Global cardiogenomics market analysis (2026–2030)

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Cardiogenomics Market In 2026, And How Will Its Value Evolve By 2030?

The cardiogenomics market has experienced substantial expansion in recent years. Projections indicate it will grow from $1.74 billion in 2025 to $2.02 billion in 2026, at a compound annual growth rate (CAGR) of 15.7%. This historical growth can be primarily attributed to the increasing prevalence of cardiovascular diseases, advancements in genetic testing technologies, growth in clinical genomics research, wider availability of molecular diagnostics, and rising awareness of inherited heart conditions.

The cardiogenomics market size is anticipated to undergo rapid growth over the coming years, projected to reach $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period is primarily attributed to factors such as the increasing demand for personalized cardiac care, the broadening of precision medicine initiatives, rising investments in genomic research, the growing adoption of AI-driven genomic analysis, and the enhanced integration of genomics into routine cardiology practice. Moreover, key trends expected during this period include an increasing application of genetic risk profiling in cardiology, a rising use of next-generation sequencing in heart disease research, the growing integration of bioinformatics platforms, the expansion of personalized cardiovascular treatment approaches, and an enhanced focus on preventive genomic screening.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report

Which Strong Drivers Are Impacting The Cardiogenomics Market Growth?

The future expansion of the cardiogenomics market is anticipated to be propelled by the rising need for personalized medicine. This healthcare approach involves customizing prevention, diagnosis, and treatment based on an individual’s unique genetic makeup, environmental influences, and lifestyle choices. The growth in personalized medicine stems from advancements in genomics, which facilitate a more profound comprehension of individual genetic differences, thereby enabling more precise, targeted therapies that enhance patient outcomes and minimize trial-and-error in treatments. Cardiogenomics contributes to personalized medicine by leveraging genetic understanding to customize the prevention, diagnosis, and treatment of cardiovascular diseases according to each person’s specific genetic profile. For instance, according to the Personalized Medicine Coalition, a US-based non-profit organization, in February 2024, it was reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The personalized treatments approved in 2023 also included seven cancer drugs and three for other diseases and conditions. Consequently, the escalating demand for personalized medicine is fostering the expansion of the cardiogenomics market.

How Is The Cardiogenomics Market Segmented Across Different Segment Categories?

The cardiogenomics market covered in this report is segmented –

1) By Product Type: Testing Kits, Reagents, Instruments, Software, Services

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies

3) By Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Testing Kits: PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits

2) By Reagents: Enzymes, Probes, Buffers

3) By Instruments: Sequencers, Genotyping instruments, Microarray Scanners

4) By Software: Data Analysis Software, Reporting Platforms, Bioinformatics Tools

5) By Services: Genetic Testing Services, Counseling Services, Data Analysis Services

Which Trends Are Contributing To Changes In The Cardiogenomics Market?

Leading companies in the cardiogenomics market are concentrating on developing innovative solutions, such as oncogenomics, to enhance the early detection and personalized treatment of cardiovascular-related cancers. Oncogenomics involves the study of cancer-related genes and their mutations to understand disease development and progression, facilitating the creation of targeted therapies and individualized treatment approaches. For instance, in April 2025, Fortis Healthcare Ltd., an India-based healthcare company, established a Fortis Institute of Genomic Medicine in India aimed at advancing genetic research and personalized medicine. This initiative transforms patient care by enabling early disease detection, precise diagnosis, and tailored treatment across specialties including oncology, cardiology, and neurology. It also empowers targeted therapies, improves treatment outcomes, and supports preventive care for hereditary conditions. The institute’s core purpose is to advance precision medicine through a multidisciplinary team and innovative technologies, making healthcare more personalized and effective for Indian patients.

Which Organizations Play A Role In The Cardiogenomics Market Landscape?

Major companies operating in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic

Get The Full Cardiogenomics Market Report:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report

Which Region Is The Largest In The Cardiogenomics Market?

North America was the largest region in the cardiogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiogenomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report

Browse Through More Reports Similar to the Global Cardiogenomics Market 2026, By The Business Research Company

Cardiac Mapping Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795